Bajetta E - Search Results

1

Chronomodulated capecitabine and adjuvant radiation in intermediate-risk to high-risk rectal cancer: a phase II study.

Bajetta E, Pietrantonio F, Buzzoni R, Ferrario E, Valvo F, Mariani L, Dotti KF, Biondani P, Formisano B, Gevorgyan A, Grassi P, Di Bartolomeo M. Bajetta E, et al. Am J Clin Oncol. 2014 Dec;37(6):545-9. doi: 10.1097/COC.0b013e31827ecd1d. Am J Clin Oncol. 2014. PMID: 23428953 Clinical Trial.

2

Capecitabine chemoradiation for rectal cancer after curative surgery.

Bajetta E, Beretta E, Di Bartolomeo M, Mariani L, Valvo F, Ferrario E, Mancin M, Dognini G, Buzzoni R. Bajetta E, et al. J Chemother. 2006 Feb;18(1):85-9. doi: 10.1179/joc.2006.18.1.85. J Chemother. 2006. PMID: 16572898

3

Capecitabine plus oxaliplatin and irinotecan regimen every other week: a phase I/II study in first-line treatment of metastatic colorectal cancer.

Bajetta E, Celio L, Ferrario E, Di Bartolomeo M, Denaro A, Dotti K, Mancin M, Bajetta R, Colombo A, Pusceddu S. Bajetta E, et al. Among authors: bajetta r. Ann Oncol. 2007 Nov;18(11):1810-6. doi: 10.1093/annonc/mdm347. Epub 2007 Sep 6. Ann Oncol. 2007. PMID: 17823385 Free article. Clinical Trial.

4

Efficacy of treatment with irinotecan and oxaliplatin combination in FU-resistant metastatic colorectal cancer patients.

Bajetta E, Beretta E, Di Bartolomeo M, Cortinovis D, Ferrario E, Dognini G, Toffolatti L, Buzzoni R. Bajetta E, et al. Oncology. 2004;66(2):132-7. doi: 10.1159/000077439. Oncology. 2004. PMID: 15138365 Clinical Trial.

5

Safety and efficacy of two different doses of capecitabine in the treatment of advanced breast cancer in older women.

Bajetta E, Procopio G, Celio L, Gattinoni L, Della Torre S, Mariani L, Catena L, Ricotta R, Longarini R, Zilembo N, Buzzoni R. Bajetta E, et al. J Clin Oncol. 2005 Apr 1;23(10):2155-61. doi: 10.1200/JCO.2005.02.167. Epub 2005 Feb 14. J Clin Oncol. 2005. PMID: 15710946 Clinical Trial.

6

Irinotecan, fluorouracil and folinic acid (FOLFIRI) as effective treatment combination for patients with advanced gastric cancer in poor clinical condition.

Beretta E, Di Bartolomeo M, Buzzoni R, Ferrario E, Mariani L, Gevorgyan A, Bajetta E. Beretta E, et al. Among authors: bajetta e. Tumori. 2006 Sep-Oct;92(5):379-83. doi: 10.1177/030089160609200502. Tumori. 2006. PMID: 17168428 Clinical Trial.

7

Feasibility of sequential therapy with FOLFIRI followed by docetaxel/cisplatin in patients with radically resected gastric adenocarcinoma. A randomized phase III trial.

Di Bartolomeo M, Buzzoni R, Mariani L, Ferrario E, Katia D, Gevorgyan A, Zilembo N, Bordonaro R, Bochicchio AM, Massidda B, Ardizzoia A, Marini G, Aitini E, Schieppati G, Comella G, Pinotti G, Palazzo S, Cicero G, Bajetta E; Italian Trial in Medical Oncology (ITMO) Group; Villa E, Fagnani D, Reguzzoni G, Agostana B, Oliani C, Kildani B, Duro M, Botta M, Mozzana R, Mantovani G. Di Bartolomeo M, et al. Among authors: bajetta e. Oncology. 2006;71(5-6):341-6. doi: 10.1159/000108575. Epub 2007 Sep 14. Oncology. 2006. PMID: 17855795 Clinical Trial.

8

Dose finding study of erlotinib combined to capecitabine and irinotecan in pretreated advanced colorectal cancer patients.

Bajetta E, Di Bartolomeo M, Buzzoni R, Ferrario E, Dotti KF, Mariani L, Bajetta R, Gevorgyan A, Venturino P, Galassi M. Bajetta E, et al. Among authors: bajetta r. Cancer Chemother Pharmacol. 2009 Jun;64(1):67-72. doi: 10.1007/s00280-008-0852-1. Epub 2008 Oct 21. Cancer Chemother Pharmacol. 2009. PMID: 18936940 Clinical Trial.

9

Feasibility study of biweekly capecitabine, oxaliplatin, and irinotecan in patients with untreated advanced gastric cancer.

Bajetta E, Verzoni E, Ferrario E, Dotti K, Gevorgyan A, Celio L. Bajetta E, et al. Tumori. 2009 Jan-Feb;95(1):43-7. doi: 10.1177/030089160909500108. Tumori. 2009. PMID: 19366055 Clinical Trial.

10

Capecitabine, oxaliplatin and irinotecan in combination, with bevacizumab (COI-B regimen) as first-line treatment of patients with advanced colorectal cancer. An Italian Trials of Medical Oncology phase II study.

Di Bartolomeo M, Ciarlo A, Bertolini A, Barni S, Verusio C, Aitini E, Pietrantonio F, Iacovelli R, Dotti KF, Maggi C, Perrone F, Bajetta E. Di Bartolomeo M, et al. Among authors: bajetta e. Eur J Cancer. 2015 Mar;51(4):473-481. doi: 10.1016/j.ejca.2014.12.020. Epub 2015 Jan 27. Eur J Cancer. 2015. PMID: 25637137 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

354 results

Search Page